Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
thyroid scintigraphy is a circumscribed hyperdense lesion surrounded by hypodense thyroid tissue. Hyperfunctioning thyroid nodules can be classified as benign or malignant, though the incidence of a hyperfunctioning cancerous nodule is extremely low [ 1
Search for other papers by Marina Morais in
Google Scholar
PubMed
Search for other papers by João Capela-Costa in
Google Scholar
PubMed
Search for other papers by Luís Matos-Lima in
Google Scholar
PubMed
Search for other papers by José Costa-Maia in
Google Scholar
PubMed
. All of these variations increase the risk of nerve injury during thyroidectomy. In studies on cadavers, the nonrecurrent inferior laryngeal nerve occurs very rarely, with an incidence of 0.3-0.8% [ 9 , 10 ]. In the largest series reported, including
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Noemi Fralassi in
Google Scholar
PubMed
Search for other papers by Chiara Secchi in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Gabriele Cevenini in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Introduction The incidence of non-medullary thyroid cancer, in particular papillary thyroid cancer (PTC), has increased in many countries over the past 20 years [ 1 - 3 ]. As a consequence, also the reported incidence of the familial form of
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Differentiated thyroid carcinoma (DTC) accounts for more than 80% of all thyroid cancers. An increasing incidence of DTC over the last decades has been reported worldwide, and is mainly due to the discovery of small papillary carcinomas [ 1
Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol, United Kingdom
Search for other papers by Clare Yvonne England in
Google Scholar
PubMed
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Matthew Beasley in
Google Scholar
PubMed
Search for other papers by Ingrid Haupt-Schott in
Google Scholar
PubMed
Search for other papers by Georgia Herbert in
Google Scholar
PubMed
Search for other papers by Charlotte Atkinson in
Google Scholar
PubMed
Background Thyroid cancer accounts for less than 1% of cancer cases in the UK. However, the incidence is increasing, and between 2014 to 2016 there were an average of 3,527 new cases of thyroid cancer annually in the UK, compared to 1,125 in
Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Search for other papers by Saleha Babli in
Google Scholar
PubMed
Search for other papers by Richard J. Payne in
Google Scholar
PubMed
Search for other papers by Elliot Mitmaker in
Google Scholar
PubMed
Search for other papers by Juan Rivera in
Google Scholar
PubMed
in the PTC-only group. There were significantly fewer patients with persistent disease in the PTC-CLT group compared with the PTC-only group (0 vs. 8.29%, respectively; p = 0.03), and a lower incidence of CI in the PTC-CLT group compared with the
Search for other papers by Leonidas H. Duntas in
Google Scholar
PubMed
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Search for other papers by Fabio Monzani in
Google Scholar
PubMed
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed
Search for other papers by Robin Patrick Peeters in
Google Scholar
PubMed
Queen Elizabeth Hospital, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
, et al: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43:55-68. 10.1111/j.1365-2265.1995.tb01894.x 7641412 4 Surks MI, Hollowell JG: Age-specific distribution of serum
Search for other papers by Jonah Robinson in
Google Scholar
PubMed
Search for other papers by Max Richardson in
Google Scholar
PubMed
Search for other papers by Janis Hickey in
Google Scholar
PubMed
Search for other papers by Andy James in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Search for other papers by Steve G. Ball in
Google Scholar
PubMed
Search for other papers by Richard Quinton in
Google Scholar
PubMed
Search for other papers by Margaret Morris in
Google Scholar
PubMed
Search for other papers by Margaret Miller in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Introduction Hyperthyroidism affects approximately 1% of the adult population [ 1 , 2 ]. Antithyroid drugs are commonly used to control hyperthyroidism [ 3 , 4 ]. Assuming an incidence of Graves' disease in Europe of 21/100,000 per year [ 5
Search for other papers by Mikael Nilsson in
Google Scholar
PubMed
Search for other papers by E. Dillwyn Williams in
Google Scholar
PubMed
origins of the organs involved. Good examples include Lynch syndrome where a mutated DNA repair gene is associated with an increased incidence of colon, endometrial, ovarian and other cancers, and Li Fraumeni syndrome where germline mutations in p53 are
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Yan Ren in
Google Scholar
PubMed
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Search for other papers by Claire Schvartz in
Google Scholar
PubMed
Search for other papers by Marc Colonna in
Google Scholar
PubMed
French National Registry of Childhood Solid Tumours, CHU, Nancy
Search for other papers by Brigitte Lacour in
Google Scholar
PubMed
Search for other papers by Arlette Danzon in
Google Scholar
PubMed
Search for other papers by Michel Velten in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Enora Clero in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Stéphane Maillard in
Google Scholar
PubMed
Search for other papers by Emilie Marrer in
Google Scholar
PubMed
Search for other papers by Laurent Bailly in
Google Scholar
PubMed
Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed
Université Paris-Saclay, Villejuif, France
Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed
Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Search for other papers by Mae Chappe in
Google Scholar
PubMed
Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Search for other papers by Anabel García in
Google Scholar
PubMed
Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed
Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Carole Rubino in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in